BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 31980957)

  • 1. The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence.
    Boyaji S; Merkow J; Elman RNM; Kaye AD; Yong RJ; Urman RD
    Curr Pain Headache Rep; 2020 Jan; 24(2):4. PubMed ID: 31980957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of cannabidiol (CBD) for the treatment of chronic pain.
    Urits I; Gress K; Charipova K; Habib K; Lee D; Lee C; Jung JW; Kassem H; Cornett E; Paladini A; Varrassi G; Kaye AD; Viswanath O
    Best Pract Res Clin Anaesthesiol; 2020 Sep; 34(3):463-477. PubMed ID: 33004159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Cannabidiol Safety: A Review.
    Singh C; Rao K; Yadav N; Vashist Y; Chugh P; Bansal N; Minocha N
    Curr Drug Saf; 2023; 18(4):465-473. PubMed ID: 36056846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study.
    Capano A; Weaver R; Burkman E
    Postgrad Med; 2020 Jan; 132(1):56-61. PubMed ID: 31711352
    [No Abstract]   [Full Text] [Related]  

  • 6. The Role of Cannabis, Cannabidiol and Other Cannabinoids in Chronic Pain. The Perspective of Physicians.
    Köstenberger M; Nahler G; Jones TM; Neuwersch S; Likar R
    J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):318-333. PubMed ID: 34467511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain.
    Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM
    J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study.
    Hendricks O; Andersen TE; Christiansen AA; Primdahl J; Hauge EM; Ellingsen T; Horsted TI; Bachmann AG; Loft AG; Bojesen AB; Østergaard M; Lund Hetland M; Krogh NS; Roessler KK; Petersen KH
    BMJ Open; 2019 Jun; 9(6):e028197. PubMed ID: 31167870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging challenges in the extraction, analysis and bioanalysis of cannabidiol and related compounds.
    Brighenti V; Protti M; Anceschi L; Zanardi C; Mercolini L; Pellati F
    J Pharm Biomed Anal; 2021 Jan; 192():113633. PubMed ID: 33039911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey.
    Boehnke KF; Gagnier JJ; Matallana L; Williams DA
    J Pain; 2021 Nov; 22(11):1418-1428. PubMed ID: 33992787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain.
    Überall MA
    J Pain Res; 2020; 13():399-410. PubMed ID: 32104061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    Krcevski-Skvarc N; Wells C; Häuser W
    Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Do You Know About Maryjane? A Systematic Review of the Current Data on the THC:CBD Ratio.
    Zeyl V; Sawyer K; Wightman RS
    Subst Use Misuse; 2020; 55(8):1223-1227. PubMed ID: 32124675
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding Cannabis-Based Therapeutics in Sports Medicine.
    Maurer GE; Mathews NM; Schleich KT; Slayman TG; Marcussen BL
    Sports Health; 2020; 12(6):540-546. PubMed ID: 32936058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia.
    van de Donk T; Niesters M; Kowal MA; Olofsen E; Dahan A; van Velzen M
    Pain; 2019 Apr; 160(4):860-869. PubMed ID: 30585986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomaterials-Based Electrochemical Δ
    Pazuki D; Ghosh R; Howlader MMR
    Biosensors (Basel); 2023 Mar; 13(3):. PubMed ID: 36979596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol (CBD) as a treatment of acute and chronic back pain: A case series and literature review.
    Eskander JP; Spall J; Spall A; Shah RV; Kaye AD
    J Opioid Manag; 2020; 16(3):215-218. PubMed ID: 32421842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations and Implications of Cannabidiol Use During Pregnancy.
    Sarrafpour S; Urits I; Powell J; Nguyen D; Callan J; Orhurhu V; Simopoulos T; Viswanath O; Kaye AD; Kaye RJ; Cornett EM; Yazdi C
    Curr Pain Headache Rep; 2020 Jun; 24(7):38. PubMed ID: 32524214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.